Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality

J Clin Immunol. 2022 May;42(4):738-741. doi: 10.1007/s10875-022-01241-5. Epub 2022 Mar 3.

Jesús Troya¹, Paul Bastard^{2

3

4}, Jean-Laurent Casanova^{2

3

4

5}, Laurent Abel^{2

3

5}, Aurora Pujol^{6

7

8}

¹ Department of Internal Medicine, Infanta Leonor University Hospital, 28050, Madrid, Spain. jesus.troya@salud.madrid.org.
² Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
³ Imagine Institute, University of Paris, Paris, France.
⁴ St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
⁵ Howard Hughes Medical Institute, New York, NY, USA.
⁶ Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
⁷ Centre for Biomedical Research in Network On Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
⁸ Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.

No abstract available

Publication types